Research Studies

SEFTON PARK MEDICAL CENTRE is currently working with a research technology partner known as uMed. Their accredited platform enables us to provide you with research opportunities that are highly relevant to your health circumstances.

Without the use of uMed’s technology, we may not have the time to find and engage patients who meet the requirements of the studies. This would therefore mean many patients would miss out on their chance to participate in ground-breaking research.

For further information on uMed please visit their website at www.umed.io or email

patientsupport@umed.io

SEFTON PARK MEDICAL CENTRE uses Umedeor Ltd (uMed) as a data processor to support research and care support activity. This includes accessing and secure hosting of health record data for the purpose of identifying patients who are eligible for specific research or care support projects. uMed also contacts those patients on behalf of the practice via SMS, letter, email or telephone to provide more information about the study, and to collect additional information to assess your eligibility for a certain study.

Your consent will be required before any practice data is shared externally with researchers. uMed applies the national opt-out to practice data it receives so if you wish your data is not processed for research you can do so by visiting https://www.nhs.uk/your-nhs-data-matters/

For further information on uMed please visit their website at www.umed.io or email

patientsupport@umed.io

Although there are several treatment options already available for asthma, some individuals may still have difficulty controlling their symptoms.

SEFTON PARK MEDICAL CENTRE is taking part in the FLASH study which is investigating whether a medication called Atuliflapon can improve symptoms for patients living with moderate to severe uncontrolled Asthma.

This study is recruiting male and female participants between the age of 18-55 years of age with a confirmed asthma diagnosis.

SEFTON PARK MEDICAL CENTRE is working with our research technology partner uMed to invite patients to this study. If you meet the study criteria, you may receive a text message, email or letter asking whether you would like to take part. Participation is entirely voluntary and you can opt out at any time.

If you have any questions about this study please contact the uMed nurse support team at patientsupport@umed.io.